1 Zhang X, "Urinary trypsin inhibitor attenuates lipopolysaccharide-induced acute lung injury by blocking the activation of p38 mitogen-activated protein kinase" 60 : 569-575, 2011
2 Wu H, "The real culprit in systemic lupus erythematosus : abnormal epigenetic regulation" 16 : 11013-11033, 2015
3 Grammatikos AP, "Spleen tyrosine kinase(Syk)regulates systemic lupus erythematosus(SLE)T cell signaling" 8 : e74550-, 2013
4 Goropevsek A, "STAT5phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity" 101 : 1405-1418, 2017
5 Maeda N, "Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus" 28 : 166-170, 1999
6 Satoh M, "Prevalence and sociodemographic correlates of antinuclear antibodies in the United States" 64 : 2319-2327, 2012
7 Leuchten N, "Performance of antinuclear antibodies for classifying systemic lupus erythematosus : a systematic literature review and meta-regression of diagnostic data" 70 : 428-438, 2018
8 Shiozawa S, "Pathogenesis of SLE and aiCD4T cell : new insight on autoimmunity" 79 : 428-430, 2012
9 Boren E, "Inflamm-aging : autoimmunity, and the immune-risk phenotype" 3 : 401-406, 2004
10 Wells JV, "In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases" 38 : 424-435, 1979
1 Zhang X, "Urinary trypsin inhibitor attenuates lipopolysaccharide-induced acute lung injury by blocking the activation of p38 mitogen-activated protein kinase" 60 : 569-575, 2011
2 Wu H, "The real culprit in systemic lupus erythematosus : abnormal epigenetic regulation" 16 : 11013-11033, 2015
3 Grammatikos AP, "Spleen tyrosine kinase(Syk)regulates systemic lupus erythematosus(SLE)T cell signaling" 8 : e74550-, 2013
4 Goropevsek A, "STAT5phosphorylation in CD4 T cells from patients with SLE is related to changes in their subsets and follow-up disease severity" 101 : 1405-1418, 2017
5 Maeda N, "Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus" 28 : 166-170, 1999
6 Satoh M, "Prevalence and sociodemographic correlates of antinuclear antibodies in the United States" 64 : 2319-2327, 2012
7 Leuchten N, "Performance of antinuclear antibodies for classifying systemic lupus erythematosus : a systematic literature review and meta-regression of diagnostic data" 70 : 428-438, 2018
8 Shiozawa S, "Pathogenesis of SLE and aiCD4T cell : new insight on autoimmunity" 79 : 428-430, 2012
9 Boren E, "Inflamm-aging : autoimmunity, and the immune-risk phenotype" 3 : 401-406, 2004
10 Wells JV, "In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases" 38 : 424-435, 1979
11 Pawelec G, "Immunosenescence: impact in the young as well as the old?" 108 : 1-7, 1999
12 Kim JS, "IL-7Rαlow memory CD8+T cells are significantly elevated in patients with systemic lupus erythematosus" 51 : 1587-1594, 2012
13 Sonawale A, "Evaluation of the association between CD4, CD8 and CD25 cell counts and SLE in active disease and in remission" 65 : 37-42, 2017
14 Suarez A, "Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids" 65 : 1512-1517, 2006
15 Wu Y, "Double positive CD4+CD8+ T cells : key suppressive role in the production of autoantibodies in systemic lupus erythematosus" 140 : 513-519, 2014
16 Choi BY, "Characteristics of pleural effusions in systemic lupus erythematosus : differential diagnosis of lupus pleuritis" 24 : 321-326, 2015
17 Matsushita M, "Changes of CD4/CD8 ratio and interleukin-16 in systemic lupus erythematosus" 19 : 270-274, 2000
18 Zhao L, "Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus" 31 : 951-959, 2012
19 Xu A, "Caenorhabditis elegans mom-4is required for the activation of the p38 MAPK signaling pathway in the response to Pseudomonas aeruginosa infection" 4 : 53-61, 2013
20 Zhu J, "CD4 T cells : fates, functions, and faults" 112 : 1557-1569, 2008
21 Voigt J, "Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells" 2012 : 651058-, 2012
22 Hurme M, "Autoimmunity and longevity : presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians" 128 : 407-408, 2007
23 Nilsson BO, "Antinuclear antibodies in the oldest-old women and men" 27 : 281-288, 2006
24 Song LJ, "Analysis of 15 patients with systemic lupus erythematosus manifesting with negative immunofluorescence anti-nuclear antibodies after treatment" 21 : 919-924, 2012